Clinical Research Directory
Browse clinical research sites, groups, and studies.
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy
Sponsor: Sehhoon Park
Summary
In this study, the investigators obtain wearable disease based biomarkers from patients diagnosed with cancer and undergoing chemotherapy, and simultaneously measure patient self-reported adverse events through an app to evaluate chemotherapy completion rates, emergency room visits, and frequency of CTCAE adverse events. The investigators will develop an artificial intelligence-based algorism that can predict patients' side effects based on biomarkers alone.
Official title: Developing Artificial Intelligence-based Algorism Based on Life-log Data Acquired From Wearable Device for the Prediction of Chemotherapy-induced Side Effects and Symptom
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2023-06-08
Completion Date
2026-06-30
Last Updated
2023-07-21
Healthy Volunteers
No
Interventions
Fitbit smartwatch
Patients wear the wearable to check their biomarkers and use the application to assess their quality of life and side effects at one-week intervals.
Locations (1)
Samsung Medical Center
Seoul, Gangnamgu, South Korea